Myovant Stock Financials

MYOV -  USA Stock  

USD 20.28  0.22  1.07%

Understanding current and past Myovant Sciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Myovant Sciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Myovant Sciences' assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Myovant Sciences' financials over time to get the whole picture. Myovant Sciences Free Cash Flow is fairly stable at the moment as compared to the past year. Myovant Sciences reported Free Cash Flow of 368.86 Million in 2020. Invested Capital is likely to climb to about 149.9 M in 2021, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (261 M) in 2021.
Use fundamental data analysis to check out all available financial ratios of Myovant Sciences to find out if markets are presently mispricing the entity. We were able to break down and interpolate data for thirty-four available fundamentals for Myovant Sciences, which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Myovant Sciences financials, including its debt to equity, and the relationship between the gross profit and number of employees . Given that Myovant Sciences has a price to earning of (8.56) X, we recommend you to check Myovant Sciences last-minute market performance to make sure the company can sustain itself down the road. Use Myovant Sciences to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Myovant Sciences to be traded at $19.67 in 90 days.

Search Fundamentals 

 
Refresh
With this module, you can analyze Myovant financials for your investing period. You should be able to track the changes in Myovant Sciences individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  Chance Of Financial Distress
Over 93
Myovant Sciences has more than 93 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Myovant Sciences stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Myovant Sciences' official financial statements usually reflect Myovant Sciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Myovant Sciences. For example, before you start analyzing numbers published by Myovant accountants, it's critical to develop an understanding of what Myovant Sciences' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Myovant Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Myovant Sciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Myovant Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Myovant Sciences. Please utilize our Beneish M Score to check the likelihood of Myovant Sciences' management to manipulate its earnings.

Myovant Sciences Company Summary

Myovant Sciences competes with Design Therapeutics, Edesa Biotech, Denali Therapeutics, Precision Biosciences, and Dynavax Technologies. Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for womens health and endocrine diseases. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 407 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
CUSIPG637AM102
LocationUnited Kingdom
Business Address11-12 St Jamess
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitemyovant.com
Phone44 20 7400 3351
CurrencyUSD - US Dollar

Myovant Sciences Key Financial Ratios

Generally speaking, Myovant Sciences' financial ratios allow both analysts and investors to convert raw data from Myovant Sciences' financial statements into concise, actionable information that can be used to evaluate the performance of Myovant Sciences over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Myovant Sciences reports annually and quarterly.

Myovant Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Myovant Sciences's current stock value. Our valuation model uses many indicators to compare Myovant Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Myovant Sciences competition to find correlations between indicators driving Myovant Sciences's intrinsic value. More Info.
Myovant Sciences is regarded third in cash and equivalents category among related companies. It is regarded third in cash per share category among related companies . The ratio of Cash and Equivalents to Cash per Share for Myovant Sciences is about  91,445,928 . Myovant Sciences Cash and Equivalents is fairly stable at the moment as compared to the past year. Myovant Sciences reported Cash and Equivalents of 674.49 Million in 2020

Myovant Sciences Systematic Risk

Myovant Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Myovant Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Myovant Sciences correlated with the market. If Beta is less than 0 Myovant Sciences generally moves in the opposite direction as compared to the market. If Myovant Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Myovant Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Myovant Sciences is generally in the same direction as the market. If Beta > 1 Myovant Sciences moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

About Myovant Sciences Financials

What exactly are Myovant Sciences Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Myovant Sciences' income statement, its balance sheet, and the statement of cash flows. Potential Myovant Sciences investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Myovant Sciences investors may use each financial statement separately, they are all related. The changes in Myovant Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Myovant Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
 2018 2019 2020 2021 (projected)
Current Assets166.79 M87.91 M704.64 M760.27 M
Total Assets172.98 M105.93 M725.03 M782.27 M

Myovant Sciences July 27, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Myovant Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Myovant Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Myovant Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Myovant Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Myovant Sciences's daily price indicators and compare them against related drivers.
Downside Deviation2.75
Information Ratio0.0053
Maximum Drawdown15.22
Value At Risk(4.01)
Potential Upside4.18
Additionally, see Stocks Correlation. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.